2022-08-22
Interim report second quarter, January 1 – June 30, 2022, Kancera ab (publ.), org.nr. 556806-8851
This is a translation of the interim report published in swedish on Januaryt 19th
Read More
2022-07-29
Correction: Interim report first quarter 2022, 1 January – 31 March 2022 Kancera AB (publ.), org.nr. 556806-8851
Due to technical reasons this report was only published as a press release, but did not show up in the Finacial reports section on the Kancera web page. This is now corrected. First quarter in brief January – MarchFinancial...
Read More
2022-02-18
Interim report for fourth quarter 2021, 1 January – 31 December 2021 Kancera AB (publ.), org.nr. 556806-8851
The year in brief October – DecemberFinancial summary for the fourth quarter Net sales amounted to SEK 0 million (0,0 million). R&D costs amounted to SEK 12,9 million (11,2 million). Operating profit for the fourth quarter amounted to SEK...
Read More
2021-11-19
Interim report for third quarter 2021,1 January – 30 September 2021 Kancera AB (publ.), org.nr. 556806-8851
The year in brief Juli – SeptemberFinancial summary of the third quarter Net sales amounted to SEK 0 million (0,05 million). R&D costs amounted to SEK 10,9 million (8,8 million). Operating profit for the third quarter amounted to SEK...
Read More
2021-08-20
Interim report for second quarter 2021. 1 January – 30 June 2021 Kancera AB (publ.)
Second quarter in brief as well as the period 1 January to 30 June 2021 Net sales for the period (January to June) amounted to SEK 0 million (SEK 0 million), of which the second quarter contributed SEK 0 million...
Read More
2021-05-21
Interim report for first quarter 2021, 1 January – 31 March 2021
First quarter in brief Net sales for the period (January to March) amounted to SEK 0 million (SEK 0 million). R&D costs for the period amounted to SEK 8,2 million (SEK 9,7 million). Operating profit for the period amounted...
Read More
2021-02-19
Interim report for fourth quarter 2020, 1 January – 31 December 2020
Fourth quarter in brief as well as the period 1 January – 31 December 2020 Net sales for the period (January to December) amounted to SEK 0,1 million (3,2 million), of which the fourth quarter contributed SEK 0 million...
Read More
2020-11-20
Interim report for the third quarter 2020, January 1st – September 30th, 2020
Third quarter in brief as well as the period 1 January – 30 September 2020 Net sales for the period (January to September) amounted to SEK 0,09 million (3,3 million), of which the third quarter contributed SEK 0,05 million...
Read More
2020-08-21
Interim report for the second quarter 2020. January 1st – June 30th, 2020
Second quarter in brief and the period 1 January – 30 June 2020 Net sales for the period (January to June) amounted to SEK 2,6 million (3,1 million), of which the second quarter contributed SEK 2,6 million (0)....
Read More
2020-06-10
Interim report for the first quarter 2020, 1 januari-31 March 2020 Kancera AB (publ.), org.nr. 556806-8851.
First quarter in brief 1 January – 31 March 2020 Net sales for the period (January to March) amounted to SEK 0,04 million (3,1). R&D costs for the period amounted to SEK 9,7 million (10,2). Operating profit for the...
Read More